The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)

NCT01189487 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer